Orencia
Links shared publicly online about this topic
iGuard.org - Orencia Drug Interactions, Orencia Side Effects and Orencia Patient Reviews
iguard.org — “iGuard.org - Orencia Drug Interactions, Orencia Side Effects and Orencia Patient Reviews” View full resource at iguard.org
Most Recently Shared on August 20, 2010 at 1:17 am By:
MediGuard.org Health Organization
76% of #orencia users think the good things about it outweigh the bad http://tinyurl.com/yzy4ewe
iGuard.org - Orencia Drug Interactions, Orencia Side Effects and Orencia Patient Reviews
iguard.org — “iGuard.org - Orencia Drug Interactions, Orencia Side Effects and Orencia Patient Reviews” View full resource at iguard.org
Most Recently Shared on December 21, 2009 at 1:17 pm By:
MediGuard.org Health Organization
More than 47% of #orencia users are aged 45-60 ... http://tinyurl.com/yzy4ewe
Subcutaneous Formulation of Orencia Approved for Rheumatoid Arthritis - MPR
empr.com — “The FDA has approved a subcutaneous formulation of Orencia (abatacept; Bristol-Myers Squibb) for the reduction of signs and symptoms in adults with moderate to severe rheumatoid arthritis (RA).” View full resource at empr.com
Most Recently Shared on August 1, 2011 at 2:49 pm By:
MPR News: Subcutaneous Formulation of Orencia Approved for Rheumatoid Arthritis: The FDA has approved a subcutan... http://bit.ly/njnX58
Orencia® (abatacept) | Official Website
orencia.com — “Orencia® (abatacept) | Official Website” View full resource at orencia.com
Most Recently Shared on March 10, 2012 at 11:46 pm By:
Toxic side effects of Abatacept - not worth it IMO for possible preservation of C-peptide http://t.co/HrKkfv4m t1 #diabetes clinical trials
Orencia Early Leader Among New Biologics To Treat Rheumatoid Arthritis
medicalnewstoday.com — “Sermo, the world's largest online community for physicians, announced a Sermo Event Report titled Is there any Threat to Anti-TNFs from Newer Biologic DMARDs? In the past year, the FDA has appro” View full resource at medicalnewstoday.com
Most Recently Shared on April 2, 2010 at 2:06 pm By:
MNT Arthritis News Health News
Orencia Early Leader Among New Biologics To Treat Rheumatoid Arthritis http://mnt.to/3zL8 #arthritis
Orencia treatments have begun « My life as a traveling Southern Girl
tenn2texas.wordpress.com — “Orencia treatments have begun « My life as a traveling Southern Girl” View full resource at tenn2texas.wordpress.com
Most Recently Shared on March 24, 2011 at 12:50 am By:
RT @Ciszep: Orencia treatments have begun http://wp.me/p1bUj7-2X // #rheum
NICE says no to BMS for second-line Orencia | InPharm
inpharm.com — “In final draft guidance NICE has not recommended the use of Bristol-Myers Squibb’s arthritis drug Orencia after other drugs have failed” View full resource at inpharm.com
Most Recently Shared on August 25, 2011 at 11:35 am By:
Pharmafocus Health News and Pharma
NICE says no to BMS for second-line Orencia http://ow.ly/6cnhz #nice #arthritis
Orencia wins expanded European licence | InPharm
inpharm.com — “Orencia wins expanded European licence | InPharm” View full resource at inpharm.com
Most Recently Shared on January 27, 2010 at 1:43 pm By:
Pharmafocus Health News and Pharma
Orencia wins expanded European licence. Bristol-Myers Squibb’s drug can now be used to treat juvenile arthritis. http://ow.ly/10VI5
Article > NICE final "no" for BM-S' Orencia in RA
pharmatimes.com — “Article > NICE final "no" for BM-S' Orencia in RA” View full resource at pharmatimes.com
Most Recently Shared on August 25, 2011 at 12:30 pm By:
Bristol-Myers Squibb's RA drug Orencia got the final thumbs down from U.K. cost-effectiveness agency. http://t.co/JFs85MD $BMY
Clinical data supports continued development of ORENCIA administration for rheumatoid arthritis
news-medical.net — “Bristol-Myers Squibb Company announced today that new clinical data support continued development of a subcutaneous administration of ORENCIA® (abatacept) for patients with moderate to severe rheumatoid arthritis.” View full resource at news-medical.net
Most Recently Shared on October 22, 2009 at 4:16 am By:
Lung Cancer News: Clinical data supports continued development of ORENCIA administration for r.. http://digg.com/u1EoVC
Bristol-Myers Says ORENCIA Trial Positive for Rheumatoid Arthritis Treatment
emaxhealth.com — “Rheumatoid arthritis (RA) is an autoimmune disease that leads to inflammation of the joints and surrounding tissue causing joint damage and chronic pa...” View full resource at emaxhealth.com
Most Recently Shared on August 28, 2011 at 7:49 pm By:
@dsymons Yes, that "20% improvement = success" is part of the problem. Ex here para 4: http://t.co/t9NPdmr #rheum
New Data Show That Subcutaneous Injection Of An Investigational Formulation Of ORENCIA® Provided Similar Improvemnt Compared To Intraveous Therapy
medicalnewstoday.com — “(NYSE:BMY) announced that new Phase III clinical data show that a weekly subcutaneous injection of an investigational formulation of ORENCIA® (abatacept), following a single intravenous (I.V.)” View full resource at medicalnewstoday.com
Most Recently Shared on November 10, 2010 at 5:05 pm By:
MNT Arthritis News Health News
New Data Show That Subcutaneous Injection Of An Investigational Formulation Of ORENCIA® Provided Similar Improvemn... http://mnt.to/3Mm7
European Commission Approves Orencia(R) (Abatacept) In Combination With Methotrexate For Children With Moderate To Severe pJIA
medicalnewstoday.com — “Bristol-myers squibb company (nyse: bmy) announced that on 20 january 2010, the european commission approved orencia® (abatacept) in combination with methotrexate for the treatment of moderate” View full resource at medicalnewstoday.com
Most Recently Shared on January 26, 2010 at 7:37 pm By:
European Commission Approves Orencia(R) (Abatacept) In Combination With Methotrexate For Children With Moderate To Se.. http://bit.ly/b28cOH
UPDATE 1-Bristol-Myers gets FDA ok for subcutaneous Orencia | Reuters
reuters.com — “* Drug will be commercially available in the US in Sept. July 29 (Reuters) - Biopharmaceutical company Bristol-MyersSquibb Co said the U.S. Food and Drug Administrationapproved a subcutaneous” View full resource at reuters.com
Most Recently Shared on July 30, 2011 at 1:34 pm By:
Drugs and Devices OW OW Health
Bristol-Myers gets FDA ok for subcutaneous Orencia - Reuters: RTT NewsBristol-Myers gets FDA ok for subcut... http://bit.ly/qiLwaG #drug
Orencia satisfaction and usage data | Monitoring more than 370 patients | Drug safety information | MediGuard
mediguard.org — “Orencia satisfaction and usage data | Monitoring more than 370 patients | Drug safety information | MediGuard” View full resource at mediguard.org
Most Recently Shared on May 10, 2011 at 8:17 pm By:
MediGuard.org Health Organization
94% of patients taking #orencia use it for Rheumatoid Arthritis ... http://tinyurl.com/4rkjozx
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
MediGuard.org
Live health insights from 2.5+ million users of MediGuard, the easiest way to get safety alerts and recalls for your medicines.
-
MediGuard.org
Live health insights from 2.5+ million users of MediGuard, the easiest way to get safety alerts and recalls for your medicines.
-
MPR
eMPR.com provides up-to-date, concise drug information at the point-of-care.
Advertisement
